3Paul AK,Gregor H,Sabine E,et al.Circulating P-selectin andthe risk of recurrent venous thromboembolism. Thrombosis and Haemostasis . 2007
4Ay C,Jungbauer LV,Sailer T,et al.High concentrations ofsoluble P-selectin are associated with risk of venousthromboembolism and the P-selectin thr715 variant. Clinical Chemistry . 2007
5Fox EA,Kahn SR.The relationship between inflammation andvenous thrombosis:a systematic review of clinical studies. Thrombosis and Haemostasis . 2005
6Myers DD,Hawley AE,Farris DM,et al.P-selectin and leukocyte microparticles are associated with venous thrombogenesis. Journal of Vascular Surgery . 2003
7Connor D,Joseph J,Emmett L, et al.Platelet activation in acute pulmonary embolism. Journal of Thrombosis and Haemostasis . 2007
8Kageyama K,Nakajima Y,Shibasaki M, et al.Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty. Journal of Thrombosis and Haemostasis . 2007
9Rectenwald JE,,Myers DD Jr,Hawley AE,et al.D-dimer,P-selectin,and microparticles:novel markers to predict deep venous thrombosis A pilot study. Thrombosis and Haemostasis . 2005
10Wakefield,TW,Henke,PK.The role of inflammation in early and late venous thrombosis: are there clinical implications?. Seminars in Vascular Surgery . 2005
二级参考文献17
1Anderson DR, Wells PS, Stiell I , et al. Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D - dimer testing. J Emerg Med,2000, 19: 225- 230.
2Wells PS, Anderson DR, Ginsberg J. Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. Semin Thromb Hemost, 2000, 26: 643-656.
3Ruggeri ZM. Structure of yon Willebrand factor and its function in platlet adhesion and thrombus formation. Best Pract Res Clin Heamatol, 2001,14:257 - 279.
4Hantson L, Deweerdt W, De Keyser J, et al. The European Stroke Scale. Stroke, 1994. 25: 2215-2219.
5Meissner MH, Zierler BK, Bergelin RO, et al. Markers of plasma coagulation and tibrinolysis after acute deep venous thrombosis. J Vasc Surg, 2000, 32: 870-880.
6TOMER A.Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry[J].J Biol Regul Homeost Agents,2004,18(2):172-177.
7GARCIA-MARTINEZ M C,LABIOS M,HERMENEGILDO C,et al.The effect of hormone replacement therapy on Ca^2+ mobilization and P-selectin (CD62P) expression in platelets examined under flow cytometry[J].Blood Coagul Fibrinolysis,2004,15(1):1-8.
8MADAN M,BERKOWITZ S D,TCHENG J E.Glycoprotein Ⅱb/Ⅲa integrin blockade[J].Circulation,1998,98(23):2629-2635.
9YAMAMOTO J,KOVACS I B.Shear-induced in-vitro haemostasis/thrombosis tests: the benefit of using native blood[J].Blood Coagulation & Fibrinolysis,2003,14(8):697-702.
10IKEDA Y,HANDA M,MURATA M,et al.A new approach to antiplatelet therapy: inhibitor of GPⅠb/Ⅴ/Ⅸ-vWF interaction[J].Haemostasis,2000,30(suppl 3):44-52.
3Kitchens CS. Concept of hypercoagulability., a review of its development, clinical application, and recent pro- gress[J]. Semin Thromb Hemost, 1985, 11 (3) : 293- 315.
4Smith EB, Parvizi J, Purtill JJ. Delayed surgery for pa- tients with femur and hip fractures-risk of deep venous thrombosis[J]. J Trauma, 2011,70(6) :E113-E116.
5Brill A, Fuchs TA, Chauhan AK, et al. yon Wille- brand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models[J]. Blood, 2011, 117(4):1400-1407.
6Motto D. Clues to DVT pathogenesis[J]. Blood, 2011, 117(4) : 1106 -1107.
7Antonopoulos CN, Sfyroeras GS, Kakisis JD, et al. The role of soluble P selectin in the diagnosis of venous thromboembolism[J]. Thromb Res, 2014, 133 (1) : 17-24.
